{"id":"NCT00558259","sponsor":"Boehringer Ingelheim","briefTitle":"Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE","officialTitle":"Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long-term Prevention of Recurrent Symptomatic Proximal Venous Thromboembolism in Patients With Symptomatic Deep-vein Thrombosis or Pulmonary Embolism.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2011-02","completion":null,"firstPosted":"2007-11-14","resultsPosted":"2012-03-02","lastUpdate":"2014-06-27"},"enrollment":1353,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Venous Thromboembolism"],"interventions":[{"type":"DRUG","name":"dabigatran etexilate 150 mg twice daily (BID)","otherNames":[]},{"type":"DRUG","name":"matching placebo twice daily (BID)","otherNames":[]}],"arms":[{"label":"dabigatran etexilate 150 mg BID","type":"EXPERIMENTAL"},{"label":"matching placebo twice daily (BID)","type":"PLACEBO_COMPARATOR"}],"summary":"The primary efficacy objective is to evaluate whether dabigatran etexilate is superior to placebo in the long-term prevention of recurrent symptomatic venous thrombo-embolism (VTE) in patients with symptomatic deep-vein thrombosis (DVT) or pulmonary embolism (PE) who completed 6 to 18 months of treatment with vitamin K antagonist (VKA).","primaryOutcome":{"measure":"Centrally Confirmed Symptomatic Recurrent Venous Thrombotic Events (VTE) Including Unexplained Death During the Intended Treatment Period","timeFrame":"6 months","effectByArm":[{"arm":"Dabigatran","deltaMin":3,"sd":0},{"arm":"Placebo","deltaMin":37,"sd":0}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":147,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","Estonia","Germany","Italy","Latvia","Lithuania","Netherlands","New Zealand","Poland","Russia","Singapore","South Africa","South Korea","Sweden","Switzerland","Thailand"]},"refs":{"pmids":["24081972","23425163"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":47,"n":684},"commonTop":[]}}